Showing results (271-280 of 278) with videos related to
Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 278 results.
The Journal of Clinical Investigation|October 24, 2018
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunityHui-Ming Chen, William van der Touw, Yuan Shuo Wang, et al.Bioorganic & Medicinal Chemistry Letters|August 15, 2015
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic coresDeyi Zhang, Maria-Jesus Blanco, Bai-Ping Ying, et al.Journal of Ginseng Research|August 22, 2025
Ginsenoside Rb1 ameliorates post-doxorubicin treatment myocardial hypertrophy via CaN/NFATc4/GATA4Jin-Jin Chang, Li-Xia Xu, Wen-Jing Yi, et al.Elife|November 9, 2021
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modelingJoseph D Butner, Geoffrey V Martin, Zhihui Wang, et al.Scientific Reports|August 14, 2021
Association of free fatty acid binding protein with central aortic stiffness, myocardial dysfunction and preserved ejection fraction heart failureChih-Hsuan Yen, Jiun-Lu Lin, Kuo-Tzu Sung, et al.Science Translational Medicine|December 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancerAndrew W Chung, Kartik Anand, Ann C Anselme, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 23, 2023
Diagnostic accuracy of algorithms to define incident and second hip fractures: A Taiwan validation studyShau-Huai Fu, Ping-Ying Yu, Chung-Yi Li, et al.Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safetyTimothy I Richardson, Scott A Frank, Minmin Wang, et al.Pageof 28